Amgen "buy," target price reduced

27.01.09 - Jefferies & Co

NEW YORK, January 27 (newratings.com) - Analysts at Jefferies & Co reiterate their "buy" rating on Amgen (AMGN). The target price has been reduced from $71 to $66.